These findings implied a close molecular connection between AR and FOXA1, however, the clear genetic or clinical implications of these biomarkers on tumor biology and patient prognosis have not been fully explained according to ER status of breast cancer, especially in ER-positive tumors. The gene discussed is FOXA1; the disease is neoplasm.